Stomach Cancer Trial, Recruiting (NCT02526095)

Stomach Cancer Trial, Recruiting NCT02526095 Sponsor: University Hospital, Lille Condition: Stomach Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT02526095 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stomach Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with esophageal cancer, gastric (stomach) cancer, or cancer at the junction between the esophagus and stomach, confirmed by biopsy, regardless of the cancer type, stage, or planned treatment
People who have not yet received any treatment for this cancer, or who have only received pre-surgery/pre-treatment therapy (called neoadjuvant treatment)
People aged 18 or older
People who are enrolled in a social protection (healthcare coverage) scheme
People who are willing to sign a consent form agreeing to blood samples being taken, completing questionnaires, and allowing their patient information to be collected

Who may not be able to join:

People under the age of 18
People who are in custody or under legal supervision, including those under guardianship
People who do not speak French
People who are not able to give their own informed consent
People who have already been included in the FREGAT database (a related patient registry)
People who do not wish to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 12 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Guillaume Piessen, MD, PhD, University Hospital, Lille

Phone: +3320444407

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT02526095

Sponsor: University Hospital, Lille

Phase: Not Applicable

Status: Recruiting

Condition: Stomach Cancer

Trial contact: +3320444407

More information: https://clinicaltrials.gov/study/NCT02526095

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with esophageal cancer, gastric (stomach) cancer, or cancer at the junction between the esophagus and stomach, confirmed by biopsy, regardless of the cancer type, stage, or planned treatment
People who have not yet received any treatment for this cancer, or who have only received pre-surgery/pre-treatment therapy (called neoadjuvant treatment)
People aged 18 or older
People who are enrolled in a social protection (healthcare coverage) scheme
People who are willing to sign a consent form agreeing to blood samples being taken, completing questionnaires, and allowing their patient information to be collected

Who may not be able to join:

People under the age of 18
People who are in custody or under legal supervision, including those under guardianship
People who do not speak French
People who are not able to give their own informed consent
People who have already been included in the FREGAT database (a related patient registry)
People who do not wish to participate

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 12 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Lille

Registry

ClinicalTrials.gov

Start date

1 June 2014

Est. completion

1 May 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

DIsease free survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov